Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roxana Rustomjee

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Plos One|July 7, 2015
Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South AfricaJennifer R Lim, Neel R Gandhi, Thuli Mthiyane, et al.
Vaccines|September 23, 2022
Bridging Animal and Human Data in Pursuit of Vaccine LicensureCourtney L Finch, William E Dowling, Thomas H King, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulationsWynand Smythe, Corinne S Merle, Roxana Rustomjee, et al.
The Lancet. Infectious Diseases|April 3, 2016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsAlimuddin Zumla, Martin Rao, Robert S Wallis, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patientsWynand Smythe, Akash Khandelwal, Corinne Merle, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
The Lancet. Infectious Diseases|December 18, 2018
Transmission of drug-resistant tuberculosis in HIV-endemic settingsPalwasha Y Khan, Tom A Yates, Muhammad Osman, et al.
The New England Journal of Medicine|October 23, 2014
A four-month gatifloxacin-containing regimen for treating tuberculosisCorinne S Merle, Katherine Fielding, Omou Bah Sow, et al.
The New England Journal of Medicine|September 10, 2010
Rapid molecular detection of tuberculosis and rifampin resistanceCatharina C Boehme, Pamela Nabeta, Doris Hillemann, et al.
The New England Journal of Medicine|June 5, 2009
The diarylquinoline TMC207 for multidrug-resistant tuberculosisAndreas H Diacon, Alexander Pym, Martin Grobusch, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Plos One|July 7, 2015
Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South AfricaJennifer R Lim, Neel R Gandhi, Thuli Mthiyane, et al.
Vaccines|September 23, 2022
Bridging Animal and Human Data in Pursuit of Vaccine LicensureCourtney L Finch, William E Dowling, Thomas H King, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulationsWynand Smythe, Corinne S Merle, Roxana Rustomjee, et al.
The Lancet. Infectious Diseases|April 3, 2016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsAlimuddin Zumla, Martin Rao, Robert S Wallis, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patientsWynand Smythe, Akash Khandelwal, Corinne Merle, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
The Lancet. Infectious Diseases|December 18, 2018
Transmission of drug-resistant tuberculosis in HIV-endemic settingsPalwasha Y Khan, Tom A Yates, Muhammad Osman, et al.
The New England Journal of Medicine|October 23, 2014
A four-month gatifloxacin-containing regimen for treating tuberculosisCorinne S Merle, Katherine Fielding, Omou Bah Sow, et al.
The New England Journal of Medicine|September 10, 2010
Rapid molecular detection of tuberculosis and rifampin resistanceCatharina C Boehme, Pamela Nabeta, Doris Hillemann, et al.
The New England Journal of Medicine|June 5, 2009
The diarylquinoline TMC207 for multidrug-resistant tuberculosisAndreas H Diacon, Alexander Pym, Martin Grobusch, et al.
Pageof 5